Lichenoid Drug Eruption Secondary to Growth Hormone in a Case of Noonan’s Syndrome

Lichenoid drug reactions (LDRs) are a type of cutaneous adverse drug reaction that clinically resembles lichen planus and demonstrates lichenoid tissue reaction on histopathology. These have been implicated by various topical, oral, and injectable medications. Noonan’s syndrome (NS) is an autosomal...

Full description

Saved in:
Bibliographic Details
Main Authors: Uffra Shaikh, Swagata Tambe, Kirti Jangid, Prashant Patil
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2025-04-01
Series:Indian Journal of Paediatric Dermatology
Subjects:
Online Access:https://journals.lww.com/10.4103/ijpd.ijpd_1_25
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Lichenoid drug reactions (LDRs) are a type of cutaneous adverse drug reaction that clinically resembles lichen planus and demonstrates lichenoid tissue reaction on histopathology. These have been implicated by various topical, oral, and injectable medications. Noonan’s syndrome (NS) is an autosomal dominant disorder with skeletal deformity, particularly short stature as a common feature for which growth hormone (GH) therapy is effective. Here, we present a 16-year-old male with NS who developed lichenoid dermatitis on initiation of injectable GH therapy and showed remission with oral apremilast and after withdrawal of the injectable GH therapy.
ISSN:2319-7250
2319-7269